Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B

Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B

Background and aims: The serum metabolites changes in patients with hepatitis B virus (HBV)-related cirrhosis as progression. Peroxisome proliferator-activated receptor gamma (PPARγ) is closely related to lipid metabolism in cirrhotic liver. However, the relationship between fatty acids and the expr...

Full description

Bibliographic Details
Main Authors:	Hai-Na Fan, Zhi-Min Zhao, Kai Huang, Xiao-Ning Wang, Yun-Kai Dai, Cheng-Hai Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Pharmacology
Subjects:	metabolomics PPAR γ HBV-related cirrhosis regression fatty acids
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1329266/full

Similar Items

PPARγ-dependent hepatic macrophage switching acts as a central hub for hUCMSC-mediated alleviation of decompensated liver cirrhosis in rats
by: Yunqi Yao, et al.
Published: (2023-07-01)

Single-cell RNA transcriptomics reveals differences in the immune status of alcoholic and hepatitis B virus-related liver cirrhosis
by: Pengpeng Zhang, et al.
Published: (2023-02-01)

High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
by: Jan-Hendrik Bockmann, et al.
Published: (2021-04-01)

Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
by: Cheng R, et al.
Published: (2022-09-01)

Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis<subtitle>HHV-8 and mild cirrhosis</subtitle>
by: Kuo-Chih Tseng, et al.
Published: (2017-01-01)

Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats
by: Szu-Yu Liu, et al.
Published: (2021-11-01)

On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
by: Zeyuan Yang, et al.
Published: (2023-10-01)

Superinfection of hepatitis E as a factor in the development of acute hepatic encephalopathy on the background of HBV-cirrhosis of the liver
by: S V Baramzina, et al.
Published: (2018-02-01)

PM2.5 induced liver lipid metabolic disorders in C57BL/6J mice
by: Chenxiao Zhang, et al.
Published: (2023-09-01)

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
by: Da Jung Kim, et al.
Published: (2019-10-01)

Mulberry and Hippophae-based solid beverage promotes weight loss in rats by antagonizing white adipose tissue PPARγ and FGFR1 signaling
by: Xiao-Ting Zhou, et al.
Published: (2024-03-01)

Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study
by: Xu Huang, et al.
Published: (2022-11-01)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
by: Michelle Junyi He, et al.
Published: (2022-11-01)

Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma
by: Zhiyong Du, et al.
Published: (2023-05-01)

Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidation
by: Sen‐bo Yan, et al.
Published: (2023-12-01)

Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis
by: Benard Aliwa, et al.
Published: (2023-12-01)

Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies
by: Rui Li, et al.
Published: (2023-10-01)

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
by: Yuji Nakano, et al.
Published: (2020-07-01)

The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels
by: Huanyu Xiang, et al.
Published: (2023-09-01)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
by: O. I. Urazova, et al.
Published: (2014-07-01)

Peroxisome Proliferator-Activated Receptor α Has a Protective Effect on Fatty Liver Caused by Excessive Sucrose Intake
by: Tomomi Yamazaki, et al.
Published: (2022-09-01)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
by: Francesco Paolo Russo, et al.
Published: (2022-01-01)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
by: Boram Kim, et al.
Published: (2020-09-01)

Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis
by: Yun-kai Dai, et al.
Published: (2023-11-01)

Relationship between PPAR‐γ gene polymorphisms and ischemic stroke risk: A meta‐analysis
by: Fan Cheng, et al.
Published: (2021-12-01)

Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran
by: Fatemeh Akhavan Anvari, et al.
Published: (2014-03-01)

Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPARγ
by: Tingjun Liu, et al.
Published: (2023-09-01)

PPARγ modulates long chain fatty acid processing in the intestinal epithelium
by: Duszka, Kalina, et al.
Published: (2018)

Single-cell RNA sequencing reveals the mediatory role of cancer-associated fibroblast PTN in hepatitis B virus cirrhosis-HCC progression
by: Chenhong Lin, et al.
Published: (2023-05-01)

Naringenin and β-carotene convert human white adipocytes to a beige phenotype and elevate hormone- stimulated lipolysis
by: Ann A. Coulter, et al.
Published: (2023-04-01)

Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis
by: An Tu, et al.
Published: (2024-02-01)

Editorial: The current challenges underlying hepatitis D virus infection
by: Romina Salpini, et al.
Published: (2024-01-01)

Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis
by: Angela Horvath, et al.
Published: (2022-02-01)

Comparative untargeted metabolomics analysis of serum metabolic alterations in patients infected with hepatitis B virus genotypes B and C
by: Min Deng, et al.
Published: (2023-10-01)

The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease
by: Ahmed A. Al-Qahtani, et al.
Published: (2018-10-01)

Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor
by: Balaji Venkataraman, et al.
Published: (2021-04-01)

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
by: Carmen Ciavarella, et al.
Published: (2020-04-01)

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adiposity and hepatic steatosis
by: Haifang Li, et al.
Published: (2021-12-01)

Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma
by: Qingquan Bai, et al.
Published: (2023-12-01)

Differentiation between alcohol-associated cirrhosis and hepatitis B-associated cirrhosis based on hepatic complications and psychological symptoms
by: Yun-Fang Liang, et al.
Published: (2023-01-01)